aluates Reports

$ 0.0

Automative

Global Viral Vector Vaccines Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-30G10233

Global and United States Viral Vector Vaccines Market Report Forecast 2022 2028

BUY CHAPTERS

Global Viral Vector Vaccines Market Insights, Forecast to 2030

Code: QYRE-Auto-30G10233

Report

December 2024

Pages:97

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Advanced Bioscience Laboratories

Viral Vector Vaccines Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Viral Vector Vaccines Market

Viral vector vaccines combine many of the positive qualities of DNA vaccines with those of live attenuated vaccines.

The global Viral Vector Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Viral Vector Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Viral Vector Vaccines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Viral Vector Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Viral Vector Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Viral Vector Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Viral Vector Vaccines sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Viral Vector Vaccines Market Report

Report Metric	Details
Report Name	Viral Vector Vaccines Market
CAGR	5%
Segment by Type	Adenovirus Fowlpox Virus Attenuated Yellow Fever Vaccinia Virus Vectors Others
Segment by Application	Hospitals Clinics Others
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Brammer Bio, Creative Biogene, GE Healthcare, Pfizer, Sanofi
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Viral Vector Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Viral Vector Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Viral Vector Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Viral Vector Vaccines Market report?

Ans: The main players in the Viral Vector Vaccines Market are Brammer Bio, Creative Biogene, GE Healthcare, Pfizer, Sanofi

What are the Application segmentation covered in the Viral Vector Vaccines Market report?

Ans: The Applications covered in the Viral Vector Vaccines Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Viral Vector Vaccines Market report?

Ans: The Types covered in the Viral Vector Vaccines Market report are Adenovirus, Fowlpox Virus, Attenuated Yellow Fever, Vaccinia Virus Vectors, Others

1 Study Coverage

1.1 Viral Vector Vaccines Product Introduction

1.2 Market by Type

1.2.1 Global Viral Vector Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Adenovirus

1.2.3 Fowlpox Virus

1.2.4 Attenuated Yellow Fever

1.2.5 Vaccinia Virus Vectors

1.2.6 Others

1.3 Market by Application

1.3.1 Global Viral Vector Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Viral Vector Vaccines Sales Estimates and Forecasts 2019-2030

2.2 Global Viral Vector Vaccines Revenue by Region

2.2.1 Global Viral Vector Vaccines Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Viral Vector Vaccines Revenue by Region (2019-2024)

2.2.3 Global Viral Vector Vaccines Revenue by Region (2025-2030)

2.2.4 Global Viral Vector Vaccines Revenue Market Share by Region (2019-2030)

2.3 Global Viral Vector Vaccines Sales Estimates and Forecasts 2019-2030

2.4 Global Viral Vector Vaccines Sales by Region

2.4.1 Global Viral Vector Vaccines Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Viral Vector Vaccines Sales by Region (2019-2024)

2.4.3 Global Viral Vector Vaccines Sales by Region (2025-2030)

2.4.4 Global Viral Vector Vaccines Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Viral Vector Vaccines Sales by Manufacturers

3.1.1 Global Viral Vector Vaccines Sales by Manufacturers (2019-2024)

3.1.2 Global Viral Vector Vaccines Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Viral Vector Vaccines in 2023

3.2 Global Viral Vector Vaccines Revenue by Manufacturers

3.2.1 Global Viral Vector Vaccines Revenue by Manufacturers (2019-2024)

3.2.2 Global Viral Vector Vaccines Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Viral Vector Vaccines Revenue in 2023

3.3 Global Key Players of Viral Vector Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Viral Vector Vaccines Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Viral Vector Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Viral Vector Vaccines, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Viral Vector Vaccines, Product Offered and Application

3.8 Global Key Manufacturers of Viral Vector Vaccines, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Viral Vector Vaccines Sales by Type

4.1.1 Global Viral Vector Vaccines Historical Sales by Type (2019-2024)

4.1.2 Global Viral Vector Vaccines Forecasted Sales by Type (2025-2030)

4.1.3 Global Viral Vector Vaccines Sales Market Share by Type (2019-2030)

4.2 Global Viral Vector Vaccines Revenue by Type

4.2.1 Global Viral Vector Vaccines Historical Revenue by Type (2019-2024)

4.2.2 Global Viral Vector Vaccines Forecasted Revenue by Type (2025-2030)

4.2.3 Global Viral Vector Vaccines Revenue Market Share by Type (2019-2030)

4.3 Global Viral Vector Vaccines Price by Type

4.3.1 Global Viral Vector Vaccines Price by Type (2019-2024)

4.3.2 Global Viral Vector Vaccines Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Viral Vector Vaccines Sales by Application

5.1.1 Global Viral Vector Vaccines Historical Sales by Application (2019-2024)

5.1.2 Global Viral Vector Vaccines Forecasted Sales by Application (2025-2030)

5.1.3 Global Viral Vector Vaccines Sales Market Share by Application (2019-2030)

5.2 Global Viral Vector Vaccines Revenue by Application

5.2.1 Global Viral Vector Vaccines Historical Revenue by Application (2019-2024)

5.2.2 Global Viral Vector Vaccines Forecasted Revenue by Application (2025-2030)

5.2.3 Global Viral Vector Vaccines Revenue Market Share by Application (2019-2030)

5.3 Global Viral Vector Vaccines Price by Application

5.3.1 Global Viral Vector Vaccines Price by Application (2019-2024)

5.3.2 Global Viral Vector Vaccines Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Viral Vector Vaccines Market Size by Type

6.1.1 US & Canada Viral Vector Vaccines Sales by Type (2019-2030)

6.1.2 US & Canada Viral Vector Vaccines Revenue by Type (2019-2030)

6.2 US & Canada Viral Vector Vaccines Market Size by Application

6.2.1 US & Canada Viral Vector Vaccines Sales by Application (2019-2030)

6.2.2 US & Canada Viral Vector Vaccines Revenue by Application (2019-2030)

6.3 US & Canada Viral Vector Vaccines Market Size by Country

6.3.1 US & Canada Viral Vector Vaccines Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Viral Vector Vaccines Sales by Country (2019-2030)

6.3.3 US & Canada Viral Vector Vaccines Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Viral Vector Vaccines Market Size by Type

7.1.1 Europe Viral Vector Vaccines Sales by Type (2019-2030)

7.1.2 Europe Viral Vector Vaccines Revenue by Type (2019-2030)

7.2 Europe Viral Vector Vaccines Market Size by Application

7.2.1 Europe Viral Vector Vaccines Sales by Application (2019-2030)

7.2.2 Europe Viral Vector Vaccines Revenue by Application (2019-2030)

7.3 Europe Viral Vector Vaccines Market Size by Country

7.3.1 Europe Viral Vector Vaccines Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Viral Vector Vaccines Sales by Country (2019-2030)

7.3.3 Europe Viral Vector Vaccines Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Viral Vector Vaccines Market Size

8.1.1 China Viral Vector Vaccines Sales (2019-2030)

8.1.2 China Viral Vector Vaccines Revenue (2019-2030)

8.2 China Viral Vector Vaccines Market Size by Application

8.2.1 China Viral Vector Vaccines Sales by Application (2019-2030)

8.2.2 China Viral Vector Vaccines Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Viral Vector Vaccines Market Size by Type

9.1.1 Asia Viral Vector Vaccines Sales by Type (2019-2030)

9.1.2 Asia Viral Vector Vaccines Revenue by Type (2019-2030)

9.2 Asia Viral Vector Vaccines Market Size by Application

9.2.1 Asia Viral Vector Vaccines Sales by Application (2019-2030)

9.2.2 Asia Viral Vector Vaccines Revenue by Application (2019-2030)

9.3 Asia Viral Vector Vaccines Sales by Region

9.3.1 Asia Viral Vector Vaccines Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Viral Vector Vaccines Revenue by Region (2019-2030)

9.3.3 Asia Viral Vector Vaccines Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Viral Vector Vaccines Market Size by Type

10.1.1 Middle East, Africa and Latin America Viral Vector Vaccines Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Viral Vector Vaccines Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Viral Vector Vaccines Market Size by Application

10.2.1 Middle East, Africa and Latin America Viral Vector Vaccines Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Viral Vector Vaccines Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Viral Vector Vaccines Sales by Country

10.3.1 Middle East, Africa and Latin America Viral Vector Vaccines Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Viral Vector Vaccines Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Viral Vector Vaccines Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Advanced Bioscience Laboratories

11.1.1 Advanced Bioscience Laboratories Company Information

11.1.2 Advanced Bioscience Laboratories Overview

11.1.3 Advanced Bioscience Laboratories Viral Vector Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Advanced Bioscience Laboratories Viral Vector Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Advanced Bioscience Laboratories Recent Developments

11.2 Boehringer Ingelheim

11.2.1 Boehringer Ingelheim Company Information

11.2.2 Boehringer Ingelheim Overview

11.2.3 Boehringer Ingelheim Viral Vector Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Boehringer Ingelheim Viral Vector Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Boehringer Ingelheim Recent Developments

11.3 Brammer Bio

11.3.1 Brammer Bio Company Information

11.3.2 Brammer Bio Overview

11.3.3 Brammer Bio Viral Vector Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Brammer Bio Viral Vector Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Brammer Bio Recent Developments

11.4 Creative Biogene

11.4.1 Creative Biogene Company Information

11.4.2 Creative Biogene Overview

11.4.3 Creative Biogene Viral Vector Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Creative Biogene Viral Vector Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Creative Biogene Recent Developments

11.5 GE Healthcare

11.5.1 GE Healthcare Company Information

11.5.2 GE Healthcare Overview

11.5.3 GE Healthcare Viral Vector Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 GE Healthcare Viral Vector Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 GE Healthcare Recent Developments

11.6 Pfizer

11.6.1 Pfizer Company Information

11.6.2 Pfizer Overview

11.6.3 Pfizer Viral Vector Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Pfizer Viral Vector Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Pfizer Recent Developments

11.7 Sanofi

11.7.1 Sanofi Company Information

11.7.2 Sanofi Overview

11.7.3 Sanofi Viral Vector Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Sanofi Viral Vector Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Sanofi Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Viral Vector Vaccines Industry Chain Analysis

12.2 Viral Vector Vaccines Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Viral Vector Vaccines Production Mode & Process

12.4 Viral Vector Vaccines Sales and Marketing

12.4.1 Viral Vector Vaccines Sales Channels

12.4.2 Viral Vector Vaccines Distributors

12.5 Viral Vector Vaccines Customers

13 Market Dynamics

13.1 Viral Vector Vaccines Industry Trends

13.2 Viral Vector Vaccines Market Drivers

13.3 Viral Vector Vaccines Market Challenges

13.4 Viral Vector Vaccines Market Restraints

14 Key Findings in The Global Viral Vector Vaccines Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Advanced Bioscience Laboratories

List of Tables

Table 1. Global Viral Vector Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Adenovirus

Table 3. Major Manufacturers of Fowlpox Virus

Table 4. Major Manufacturers of Attenuated Yellow Fever

Table 5. Major Manufacturers of Vaccinia Virus Vectors

Table 6. Major Manufacturers of Others

Table 7. Global Viral Vector Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Viral Vector Vaccines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 9. Global Viral Vector Vaccines Revenue by Region (2019-2024) & (US$ Million)

Table 10. Global Viral Vector Vaccines Revenue by Region (2025-2030) & (US$ Million)

Table 11. Global Viral Vector Vaccines Revenue Market Share by Region (2019-2024)

Table 12. Global Viral Vector Vaccines Revenue Market Share by Region (2025-2030)

Table 13. Global Viral Vector Vaccines Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Viral Vector Vaccines Sales by Region (2019-2024) & (K Units)

Table 15. Global Viral Vector Vaccines Sales by Region (2025-2030) & (K Units)

Table 16. Global Viral Vector Vaccines Sales Market Share by Region (2019-2024)

Table 17. Global Viral Vector Vaccines Sales Market Share by Region (2025-2030)

Table 18. Global Viral Vector Vaccines Sales by Manufacturers (2019-2024) & (K Units)

Table 19. Global Viral Vector Vaccines Sales Share by Manufacturers (2019-2024)

Table 20. Global Viral Vector Vaccines Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 21. Global Viral Vector Vaccines Revenue Share by Manufacturers (2019-2024)

Table 22. Global Key Players of Viral Vector Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

Table 23. Viral Vector Vaccines Price by Manufacturers 2019-2024 (USD/Unit)

Table 24. Global Viral Vector Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 25. Global Viral Vector Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Vaccines as of 2023)

Table 26. Global Key Manufacturers of Viral Vector Vaccines, Manufacturing Base Distribution and Headquarters

Table 27. Global Key Manufacturers of Viral Vector Vaccines, Product Offered and Application

Table 28. Global Key Manufacturers of Viral Vector Vaccines, Date of Enter into This Industry

Table 29. Mergers & Acquisitions, Expansion Plans

Table 30. Global Viral Vector Vaccines Sales by Type (2019-2024) & (K Units)

Table 31. Global Viral Vector Vaccines Sales by Type (2025-2030) & (K Units)

Table 32. Global Viral Vector Vaccines Sales Share by Type (2019-2024)

Table 33. Global Viral Vector Vaccines Sales Share by Type (2025-2030)

Table 34. Global Viral Vector Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 35. Global Viral Vector Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 36. Global Viral Vector Vaccines Revenue Share by Type (2019-2024)

Table 37. Global Viral Vector Vaccines Revenue Share by Type (2025-2030)

Table 38. Viral Vector Vaccines Price by Type (2019-2024) & (USD/Unit)

Table 39. Global Viral Vector Vaccines Price Forecast by Type (2025-2030) & (USD/Unit)

Table 40. Global Viral Vector Vaccines Sales by Application (2019-2024) & (K Units)

Table 41. Global Viral Vector Vaccines Sales by Application (2025-2030) & (K Units)

Table 42. Global Viral Vector Vaccines Sales Share by Application (2019-2024)

Table 43. Global Viral Vector Vaccines Sales Share by Application (2025-2030)

Table 44. Global Viral Vector Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 45. Global Viral Vector Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 46. Global Viral Vector Vaccines Revenue Share by Application (2019-2024)

Table 47. Global Viral Vector Vaccines Revenue Share by Application (2025-2030)

Table 48. Viral Vector Vaccines Price by Application (2019-2024) & (USD/Unit)

Table 49. Global Viral Vector Vaccines Price Forecast by Application (2025-2030) & (USD/Unit)

Table 50. US & Canada Viral Vector Vaccines Sales by Type (2019-2024) & (K Units)

Table 51. US & Canada Viral Vector Vaccines Sales by Type (2025-2030) & (K Units)

Table 52. US & Canada Viral Vector Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 53. US & Canada Viral Vector Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 54. US & Canada Viral Vector Vaccines Sales by Application (2019-2024) & (K Units)

Table 55. US & Canada Viral Vector Vaccines Sales by Application (2025-2030) & (K Units)

Table 56. US & Canada Viral Vector Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 57. US & Canada Viral Vector Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 58. US & Canada Viral Vector Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 59. US & Canada Viral Vector Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 60. US & Canada Viral Vector Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 61. US & Canada Viral Vector Vaccines Sales by Country (2019-2024) & (K Units)

Table 62. US & Canada Viral Vector Vaccines Sales by Country (2025-2030) & (K Units)

Table 63. Europe Viral Vector Vaccines Sales by Type (2019-2024) & (K Units)

Table 64. Europe Viral Vector Vaccines Sales by Type (2025-2030) & (K Units)

Table 65. Europe Viral Vector Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 66. Europe Viral Vector Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 67. Europe Viral Vector Vaccines Sales by Application (2019-2024) & (K Units)

Table 68. Europe Viral Vector Vaccines Sales by Application (2025-2030) & (K Units)

Table 69. Europe Viral Vector Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 70. Europe Viral Vector Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 71. Europe Viral Vector Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 72. Europe Viral Vector Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 73. Europe Viral Vector Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 74. Europe Viral Vector Vaccines Sales by Country (2019-2024) & (K Units)

Table 75. Europe Viral Vector Vaccines Sales by Country (2025-2030) & (K Units)

Table 76. China Viral Vector Vaccines Sales by Type (2019-2024) & (K Units)

Table 77. China Viral Vector Vaccines Sales by Type (2025-2030) & (K Units)

Table 78. China Viral Vector Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 79. China Viral Vector Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 80. China Viral Vector Vaccines Sales by Application (2019-2024) & (K Units)

Table 81. China Viral Vector Vaccines Sales by Application (2025-2030) & (K Units)

Table 82. China Viral Vector Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 83. China Viral Vector Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 84. Asia Viral Vector Vaccines Sales by Type (2019-2024) & (K Units)

Table 85. Asia Viral Vector Vaccines Sales by Type (2025-2030) & (K Units)

Table 86. Asia Viral Vector Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 87. Asia Viral Vector Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 88. Asia Viral Vector Vaccines Sales by Application (2019-2024) & (K Units)

Table 89. Asia Viral Vector Vaccines Sales by Application (2025-2030) & (K Units)

Table 90. Asia Viral Vector Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 91. Asia Viral Vector Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 92. Asia Viral Vector Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 93. Asia Viral Vector Vaccines Revenue by Region (2019-2024) & (US$ Million)

Table 94. Asia Viral Vector Vaccines Revenue by Region (2025-2030) & (US$ Million)

Table 95. Asia Viral Vector Vaccines Sales by Region (2019-2024) & (K Units)

Table 96. Asia Viral Vector Vaccines Sales by Region (2025-2030) & (K Units)

Table 97. Middle East, Africa and Latin America Viral Vector Vaccines Sales by Type (2019-2024) & (K Units)

Table 98. Middle East, Africa and Latin America Viral Vector Vaccines Sales by Type (2025-2030) & (K Units)

Table 99. Middle East, Africa and Latin America Viral Vector Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 100. Middle East, Africa and Latin America Viral Vector Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 101. Middle East, Africa and Latin America Viral Vector Vaccines Sales by Application (2019-2024) & (K Units)

Table 102. Middle East, Africa and Latin America Viral Vector Vaccines Sales by Application (2025-2030) & (K Units)

Table 103. Middle East, Africa and Latin America Viral Vector Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Viral Vector Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Viral Vector Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 106. Middle East, Africa and Latin America Viral Vector Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 107. Middle East, Africa and Latin America Viral Vector Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 108. Middle East, Africa and Latin America Viral Vector Vaccines Sales by Country (2019-2024) & (K Units)

Table 109. Middle East, Africa and Latin America Viral Vector Vaccines Sales by Country (2025-2030) & (K Units)

Table 110. Advanced Bioscience Laboratories Company Information

Table 111. Advanced Bioscience Laboratories Description and Major Businesses

Table 112. Advanced Bioscience Laboratories Viral Vector Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Advanced Bioscience Laboratories Viral Vector Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 114. Advanced Bioscience Laboratories Recent Developments

Table 115. Boehringer Ingelheim Company Information

Table 116. Boehringer Ingelheim Description and Major Businesses

Table 117. Boehringer Ingelheim Viral Vector Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Boehringer Ingelheim Viral Vector Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 119. Boehringer Ingelheim Recent Developments

Table 120. Brammer Bio Company Information

Table 121. Brammer Bio Description and Major Businesses

Table 122. Brammer Bio Viral Vector Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 123. Brammer Bio Viral Vector Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 124. Brammer Bio Recent Developments

Table 125. Creative Biogene Company Information

Table 126. Creative Biogene Description and Major Businesses

Table 127. Creative Biogene Viral Vector Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 128. Creative Biogene Viral Vector Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 129. Creative Biogene Recent Developments

Table 130. GE Healthcare Company Information

Table 131. GE Healthcare Description and Major Businesses

Table 132. GE Healthcare Viral Vector Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 133. GE Healthcare Viral Vector Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 134. GE Healthcare Recent Developments

Table 135. Pfizer Company Information

Table 136. Pfizer Description and Major Businesses

Table 137. Pfizer Viral Vector Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 138. Pfizer Viral Vector Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 139. Pfizer Recent Developments

Table 140. Sanofi Company Information

Table 141. Sanofi Description and Major Businesses

Table 142. Sanofi Viral Vector Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 143. Sanofi Viral Vector Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 144. Sanofi Recent Developments

Table 145. Key Raw Materials Lists

Table 146. Raw Materials Key Suppliers Lists

Table 147. Viral Vector Vaccines Distributors List

Table 148. Viral Vector Vaccines Customers List

Table 149. Viral Vector Vaccines Market Trends

Table 150. Viral Vector Vaccines Market Drivers

Table 151. Viral Vector Vaccines Market Challenges

Table 152. Viral Vector Vaccines Market Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

List of Figures

Figure 1. Viral Vector Vaccines Product Picture

Figure 2. Global Viral Vector Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Viral Vector Vaccines Market Share by Type in 2023 & 2030

Figure 4. Adenovirus Product Picture

Figure 5. Fowlpox Virus Product Picture

Figure 6. Attenuated Yellow Fever Product Picture

Figure 7. Vaccinia Virus Vectors Product Picture

Figure 8. Others Product Picture

Figure 9. Global Viral Vector Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 10. Global Viral Vector Vaccines Market Share by Application in 2023 & 2030

Figure 11. Hospitals

Figure 12. Clinics

Figure 13. Others

Figure 14. Viral Vector Vaccines Report Years Considered

Figure 15. Global Viral Vector Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Viral Vector Vaccines Revenue 2019-2030 (US$ Million)

Figure 17. Global Viral Vector Vaccines Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 18. Global Viral Vector Vaccines Revenue Market Share by Region (2019-2030)

Figure 19. Global Viral Vector Vaccines Sales 2019-2030 ((K Units)

Figure 20. Global Viral Vector Vaccines Sales Market Share by Region (2019-2030)

Figure 21. US & Canada Viral Vector Vaccines Sales YoY (2019-2030) & (K Units)

Figure 22. US & Canada Viral Vector Vaccines Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Europe Viral Vector Vaccines Sales YoY (2019-2030) & (K Units)

Figure 24. Europe Viral Vector Vaccines Revenue YoY (2019-2030) & (US$ Million)

Figure 25. China Viral Vector Vaccines Sales YoY (2019-2030) & (K Units)

Figure 26. China Viral Vector Vaccines Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Asia (excluding China) Viral Vector Vaccines Sales YoY (2019-2030) & (K Units)

Figure 28. Asia (excluding China) Viral Vector Vaccines Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Middle East, Africa and Latin America Viral Vector Vaccines Sales YoY (2019-2030) & (K Units)

Figure 30. Middle East, Africa and Latin America Viral Vector Vaccines Revenue YoY (2019-2030) & (US$ Million)

Figure 31. The Viral Vector Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 32. The Top 5 and 10 Largest Manufacturers of Viral Vector Vaccines in the World: Market Share by Viral Vector Vaccines Revenue in 2023

Figure 33. Global Viral Vector Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 34. Global Viral Vector Vaccines Sales Market Share by Type (2019-2030)

Figure 35. Global Viral Vector Vaccines Revenue Market Share by Type (2019-2030)

Figure 36. Global Viral Vector Vaccines Sales Market Share by Application (2019-2030)

Figure 37. Global Viral Vector Vaccines Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Viral Vector Vaccines Sales Market Share by Type (2019-2030)

Figure 39. US & Canada Viral Vector Vaccines Revenue Market Share by Type (2019-2030)

Figure 40. US & Canada Viral Vector Vaccines Sales Market Share by Application (2019-2030)

Figure 41. US & Canada Viral Vector Vaccines Revenue Market Share by Application (2019-2030)

Figure 42. US & Canada Viral Vector Vaccines Revenue Share by Country (2019-2030)

Figure 43. US & Canada Viral Vector Vaccines Sales Share by Country (2019-2030)

Figure 44. U.S. Viral Vector Vaccines Revenue (2019-2030) & (US$ Million)

Figure 45. Canada Viral Vector Vaccines Revenue (2019-2030) & (US$ Million)

Figure 46. Europe Viral Vector Vaccines Sales Market Share by Type (2019-2030)

Figure 47. Europe Viral Vector Vaccines Revenue Market Share by Type (2019-2030)

Figure 48. Europe Viral Vector Vaccines Sales Market Share by Application (2019-2030)

Figure 49. Europe Viral Vector Vaccines Revenue Market Share by Application (2019-2030)

Figure 50. Europe Viral Vector Vaccines Revenue Share by Country (2019-2030)

Figure 51. Europe Viral Vector Vaccines Sales Share by Country (2019-2030)

Figure 52. Germany Viral Vector Vaccines Revenue (2019-2030) & (US$ Million)

Figure 53. France Viral Vector Vaccines Revenue (2019-2030) & (US$ Million)

Figure 54. U.K. Viral Vector Vaccines Revenue (2019-2030) & (US$ Million)

Figure 55. Italy Viral Vector Vaccines Revenue (2019-2030) & (US$ Million)

Figure 56. Russia Viral Vector Vaccines Revenue (2019-2030) & (US$ Million)

Figure 57. China Viral Vector Vaccines Sales Market Share by Type (2019-2030)

Figure 58. China Viral Vector Vaccines Revenue Market Share by Type (2019-2030)

Figure 59. China Viral Vector Vaccines Sales Market Share by Application (2019-2030)

Figure 60. China Viral Vector Vaccines Revenue Market Share by Application (2019-2030)

Figure 61. Asia Viral Vector Vaccines Sales Market Share by Type (2019-2030)

Figure 62. Asia Viral Vector Vaccines Revenue Market Share by Type (2019-2030)

Figure 63. Asia Viral Vector Vaccines Sales Market Share by Application (2019-2030)

Figure 64. Asia Viral Vector Vaccines Revenue Market Share by Application (2019-2030)

Figure 65. Asia Viral Vector Vaccines Revenue Share by Region (2019-2030)

Figure 66. Asia Viral Vector Vaccines Sales Share by Region (2019-2030)

Figure 67. Japan Viral Vector Vaccines Revenue (2019-2030) & (US$ Million)

Figure 68. South Korea Viral Vector Vaccines Revenue (2019-2030) & (US$ Million)

Figure 69. China Taiwan Viral Vector Vaccines Revenue (2019-2030) & (US$ Million)

Figure 70. Southeast Asia Viral Vector Vaccines Revenue (2019-2030) & (US$ Million)

Figure 71. India Viral Vector Vaccines Revenue (2019-2030) & (US$ Million)

Figure 72. Middle East, Africa and Latin America Viral Vector Vaccines Sales Market Share by Type (2019-2030)

Figure 73. Middle East, Africa and Latin America Viral Vector Vaccines Revenue Market Share by Type (2019-2030)

Figure 74. Middle East, Africa and Latin America Viral Vector Vaccines Sales Market Share by Application (2019-2030)

Figure 75. Middle East, Africa and Latin America Viral Vector Vaccines Revenue Market Share by Application (2019-2030)

Figure 76. Middle East, Africa and Latin America Viral Vector Vaccines Revenue Share by Country (2019-2030)

Figure 77. Middle East, Africa and Latin America Viral Vector Vaccines Sales Share by Country (2019-2030)

Figure 78. Brazil Viral Vector Vaccines Revenue (2019-2030) & (US$ Million)

Figure 79. Mexico Viral Vector Vaccines Revenue (2019-2030) & (US$ Million)

Figure 80. Turkey Viral Vector Vaccines Revenue (2019-2030) & (US$ Million)

Figure 81. Israel Viral Vector Vaccines Revenue (2019-2030) & (US$ Million)

Figure 82. GCC Countries Viral Vector Vaccines Revenue (2019-2030) & (US$ Million)

Figure 83. Viral Vector Vaccines Value Chain

Figure 84. Viral Vector Vaccines Production Process

Figure 85. Channels of Distribution

Figure 86. Distributors Profiles

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions